BOSTON Aug 22 Hedge fund manager William Ackman
said on Friday that a total of 35 shareholders who own 31
percent of Allergan Inc.' s stock have called on the
Botox maker to call a special meeting.
Ackman, whose Pershing Square Capital Management owns nearly
10 percent of Allergan's stock, has been working with Valeant
Pharmaceuticals to try and buy Allergan in a deal
valued at $49 billion.
Allergan required shareholders owning 25 percent of its
shares to submit paperwork. Pershing Square also sued the
company in Delaware to compel it to call the meeting.
(Reporting by Svea Herbst-Bayliss; Editing by Chris Reese)